Taken together, these results suggest that DCTD plays a preeminent role in the metabolic activation of 5hmdC in human leukemia, and that high DCK expression can be utilized as a potential biomarker for therapeutic use of 5hmdC in human leukemia. The gene discussed is DCTD; the disease is leukemia.